The FDA’s Guidance for the Monitoring of Clinical Investigations (1988-2010) has been removed from the FDA list of guidance documents. Instead, the FDA has released an updated version of the Bioresearch Monitoring (BIMO) Compliance Program Guidance Manual for Sponsor/CRO and Monitoring, as well as a draft guidance to reflect their expectations and recommendations related to monitoring investigation sites, monitoring systems, and investigative site oversight. In this web seminar, the content and the implications to sponsor monitoring and clinical investigation sites will be discussed.
- Explain ways in which the regulatory climate is reflected in the monitoring guidance
- Discuss the content of the guidance in relation to traditional monitoring plans
- Assess the implications of the guidance to current monitoring practices and relationships with oversight of Clinical Investigator
- Clinical Investigators and Staff
- Clinical Research Associates
- Study and Clinical Research Associate Managers
- Sponsors/CROs Clinical Operations
- Clinical Quality Compliance and Quality Assurance Professionals
Nikki Christison, B.S.
Click here for complete trainer biographies
Includes up to 20 participants at one site. All participants (up to 20) are eligible for “Certificates of Attendance,” and accreditation, provided that accreditation requirements are met. For groups larger than 20 or for additional sites, please call 1-800-856-2556 for pricing.
Barnett International is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Participants will receive 1.5 hours (0.15 CEUs) of continuing education credit for full participation, including the completion of a pre-test, post-test, and program evaluation. Barnett International will mail ACPE statements within three weeks of program completion. ACPE#: 0778-0000-11-081-L01-P. Released: 8/11.
Hold this course at your company! For more information, contact Naila Ganatra at (215) 413-2471.